Treatment of Chronic Myeloid Leukemia in Turkey
What is Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) is a rare type of bone marrow cancer, the spongy tissue inside bones that produces blood cells. This type of leukemia is characterized by an abnormal increase in the number of white blood cells in the body.
The term "chronic" in Chronic Myeloid Leukemia indicates that this type of cancer progresses more slowly compared to acute leukemias. The term "myeloid" refers to the type of cells affected, specifically the myeloid cells found in the bone marrow.
This disease may also be known by other names such as "chronic myelogenous leukemia" or "chronic granulocytic leukemia." It most commonly affects adults but can occur at any age, although it is rare in children.
Thanks to advances in treatment methods, the survival and recovery rates for people with Chronic Myeloid Leukemia have significantly improved, allowing most patients to live long and maintain a good quality of life after diagnosis.
Symptoms of Chronic Myeloid Leukemia
In many cases, there may be no clear symptoms of Chronic Myeloid Leukemia (CML), and the disease may be discovered incidentally during a routine blood test.
However, when symptoms do appear, they may include:
- Bone pain
- Easy bleeding and bruising
- Feeling full after eating small amounts of food
- Chronic fatigue and tiredness
- Persistent fever
- Unexplained weight loss
- Loss of appetite
- Pain or a feeling of fullness below the left ribs
- Excessive night sweats
- Blurred vision caused by bleeding at the back of the eye
Causes of Chronic Myeloid Leukemia (CML)
Chronic Myeloid Leukemia (CML) occurs due to genetic changes in the bone marrow cells. There is no clear cause for these changes, but doctors have gained an understanding of how the disease develops into CML.
Formation of the Philadelphia Chromosome:
Typically, human cells contain 23 pairs of chromosomes that carry DNA responsible for directing cells. In the case of Chronic Myeloid Leukemia, an abnormal exchange of chromosome parts occurs within blood cells. A part of chromosome 9 swaps places with a part of chromosome 22, resulting in a very short chromosome 22 known as the "Philadelphia chromosome," named after the city where it was discovered.
BCR-ABL Gene:
The formation of the Philadelphia chromosome leads to the creation of a new gene called BCR-ABL, which contains instructions that drive blood cells to produce a large amount of a protein called tyrosine kinase. This protein plays a key role in stimulating the abnormal and unregulated growth of white blood cells, leading to the spread of cancer.
Increased Production of Diseased Blood Cells:
Under normal circumstances, blood cells grow in the bone marrow and mature into red blood cells, white blood cells, and platelets. In Chronic Myeloid Leukemia, the tyrosine kinase enzyme causes the production of a large number of diseased white blood cells, most of which contain the Philadelphia chromosome. These diseased cells accumulate and crowd out healthy cells, leading to damage to the bone marrow.
Risk Factors for Chronic Myeloid Leukemia:
Factors that may increase the risk of developing CML include:
- Advancing Age: CML is more common among older adults.
- Gender: Men are more likely to develop CML than women.
- Exposure to Radiation: There is a link between radiation therapy for certain types of cancer and an increased risk of developing CML.
Diagnosis of Chronic Myeloid Leukemia in Turkey
The tests and procedures used to diagnose Chronic Myeloid Leukemia (CML) in Turkey include:
- Physical Exam: The doctor will thoroughly examine your body, including evaluating vital signs like pulse and blood pressure. The doctor will also check for any potential swelling in lymph nodes, the spleen, or the abdomen.
- Blood Tests: A blood sample is drawn using a needle and then sent to a lab for a complete blood count (CBC). This test measures the numbers of different types of blood cells and often shows a significant increase in white blood cells if CML is present. Blood tests also help evaluate organ function to ensure there are no abnormalities.
- Bone Marrow Tests: Bone marrow biopsy and aspiration are used to collect samples of bone marrow for lab examination. Bone marrow samples contain a solid part and a liquid part. A needle is used to withdraw a sample of the solid part during a bone marrow biopsy, while a needle is used to aspirate a sample of the liquid part during a bone marrow aspiration. These samples are usually taken from the hip bone and then sent to a lab for analysis.
- Philadelphia Chromosome Tests: Specialized tests like fluorescence in situ hybridization (FISH) analysis and polymerase chain reaction (PCR) testing are used to analyze blood or bone marrow samples to detect the presence of the Philadelphia chromosome or the BCR-ABL gene.
Stages of Chronic Myeloid Leukemia:
The stage of Chronic Myeloid Leukemia indicates how advanced the disease is. Doctors determine the stage by measuring the percentage of diseased cells compared to healthy cells in the blood or bone marrow. The higher the percentage of diseased cells, the more advanced the disease is.
The stages of Chronic Myeloid Leukemia include:
- Chronic Phase: This is the initial stage, usually the most responsive to treatment.
- Accelerated Phase: This stage represents the transition to a more aggressive phase of the disease.
- Blast Phase: The final stage, considered highly dangerous and potentially life-threatening.
Treatment of Chronic Myeloid Leukemia (CML) in Turkey
The goal of treating Chronic Myeloid Leukemia (CML) is to eliminate the cancer cells that contain the BCR-ABL gene. Treatment usually begins with targeted therapy, which helps achieve long-term remission of the disease.
Targeted Therapy:
Targeted therapy uses drugs that attack specific chemicals in cancer cells. In the case of Chronic Myeloid Leukemia, these drugs target the tyrosine kinase protein produced by the BCR-ABL gene. These drugs are known as tyrosine kinase inhibitors and are the primary treatment for most patients.
Side effects of tyrosine kinase inhibitors include skin swelling, nausea, muscle cramps, fatigue, diarrhea, and rash. Blood tests are used to monitor the presence of the BCR-ABL gene and assess treatment effectiveness.
If targeted therapy is not effective or if the cells become resistant, the doctor may recommend changing to other medications or using additional treatments.
No stage has been identified where targeted therapy can be safely stopped, so most patients continue taking these drugs even when tests show the disease is in remission. In some cases, the doctor and patient may decide together to stop treatment after evaluating the benefits and risks.
Bone Marrow Transplant:
Bone marrow transplant, or stem cell transplant, is the only treatment that can completely cure CML. However, this option is usually reserved for patients who have not responded to other treatments due to the high risks and serious complications associated with the procedure.
During a bone marrow transplant, high doses of chemotherapy are used to kill cancer cells in the bone marrow, followed by the injection of stem cells from a donor into the bloodstream. These new cells help produce healthy blood cells to replace the diseased cells.
Chemotherapy:
Chemotherapy uses powerful drugs to kill cancer cells. In some cases, chemotherapy drugs are combined with targeted therapy to treat severe cases of CML. The side effects of chemotherapy vary depending on the type of drugs used.
Preparing for Chronic Myeloid Leukemia (CML) Treatment in Turkey
When preparing for Chronic Myeloid Leukemia (CML) treatment in Turkey, it is important to be well-prepared for your medical appointment. Appointments can be short, and there are often many topics to discuss with your doctor. Here are some tips to help you prepare and ask the right questions:
What You Can Do:
- Follow Any Pre-appointment Instructions: When scheduling your appointment, ask the doctor if there are any preparations you need to make in advance, such as dietary restrictions or specific tests.
- Write Down Symptoms: Make a list of all the symptoms you are experiencing, even if they seem unrelated to your condition. This information can be useful for the doctor in thoroughly evaluating your condition.
- Prepare Personal Information: Write down details about significant changes in your life or any stresses you are facing, as they may impact your health.
- List Medications: Prepare a list of all the medications, vitamins, or supplements you are taking, as this can affect your treatment plan.
- Bring a Companion: Consider bringing a family member or friend with you to the appointment. A companion can help you remember the information the doctor provides.
- Prepare Questions: Prepare a list of questions you want to ask the doctor, arranged by importance to ensure you get the answers you need.
Important Questions to Ask the Doctor:
- What are the test results, and what do they mean?
- Do you recommend any additional tests?
- What stage of Chronic Myeloid Leukemia do I have?
- What are the available treatment options for me?
- What are the potential side effects of each treatment option?
- How will the treatment affect my daily life?
- What are the best treatment options for my condition?
- What are the chances of recovery with the proposed treatments?
- How much time do I have to make a decision about treatment?
What to Expect from Your Doctor:
The doctor is likely to ask you questions to accurately assess your condition. Being prepared to answer these questions can help speed up the diagnosis and treatment process. The questions the doctor may ask include:
- When did you first start experiencing symptoms?
- Are the symptoms constant or intermittent?
- How severe are the symptoms?
- Is there anything that improves the symptoms?
- Is there anything that worsens the symptoms?